A general term for a malignant neoplasm derived from muscular tissue. (Stedman, 25th ed)
More specific conditions that are subtypes of Myosarcoma in the MeSH hierarchy.
161 drugs (93 approved, 68 experimental)
Phase 2 trials (2)
Organization Involved with Phase 2 Indications (1)